A detailed history of Grove Bank & Trust transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Grove Bank & Trust holds 850 shares of EW stock, worth $55,386. This represents 0.01% of its overall portfolio holdings.

Number of Shares
850
Previous 860 1.16%
Holding current value
$55,386
Previous $82,000 4.88%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$84.3 - $94.31 $843 - $943
-10 Reduced 1.16%
850 $78,000
Q3 2023

Oct 30, 2023

SELL
$69.28 - $93.38 $4,918 - $6,629
-71 Reduced 7.63%
860 $59,000
Q2 2023

Jul 27, 2023

SELL
$81.41 - $94.33 $1,221 - $1,414
-15 Reduced 1.59%
931 $87,000
Q1 2023

May 10, 2023

BUY
$74.26 - $84.51 $3,935 - $4,479
53 Added 5.94%
946 $78,000
Q4 2022

Feb 03, 2023

BUY
$68.3 - $87.44 $60,991 - $78,083
893 New
893 $67,000
Q1 2018

May 07, 2018

SELL
$37.19 - $47.45 $6,322 - $8,066
-170 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $6,169 - $6,601
170
170 $19,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.